Gene · 6921
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topologic Reorganization of White Matter Connectivity Networks in Early-Blind Adolescents. | Neural Plast | 2022 | 35529452 | PubTator, text mining | PubMed |
| The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. | Comput Intell Neurosci | 2022 | 35528328 | PubTator, text mining | PubMed |
| Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes. | Front Endocrinol (Lausanne) | 2022 | 35528020 | PubTator, text mining | PubMed |
| Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. | Oncogene | 2022 | 35525905 | PubTator, text mining | PubMed |
| Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | Life Sci Alliance | 2022 | 35512830 | Swiss-Prot, curated | PubMed |
| Human Protein-l-isoaspartate O-Methyltransferase Domain-Containing Protein 1 (PCMTD1) Associates with Cullin-RING Ligase Proteins. | Biochemistry | 2022 | 35486881 | Swiss-Prot, curated | PubMed |
| CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression. | Oncogene | 2022 | 35468939 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors. | Technol Cancer Res Treat | 2022 | 35466792 | PubTator, text mining | PubMed |
| Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics. | Front Oncol | 2022 | 35463327 | PubTator, text mining | PubMed |
| Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke. | Front Aging Neurosci | 2022 | 35462700 | PubTator, text mining | PubMed |
| DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. | Genes (Basel) | 2022 | 35456435 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma | Curr Oncol | 2022 | 35448166 | PubTator, text mining | PubMed |
| Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | 35446349 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Resting-State Functional Network Topology Alterations of the Occipital Lobe Associated With Attention Impairment in Isolated Rapid Eye Movement Behavior Disorder. | Front Aging Neurosci | 2022 | 35431890 | PubTator, text mining | PubMed |
| Identification of Key CircRNAs Related to Pulmonary Tuberculosis Based on Bioinformatics Analysis. | Biomed Res Int | 2022 | 35419455 | PubTator, text mining | PubMed |
| Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodeling. | Cell Rep | 2022 | 35417684 | PubTator, text mining | PubMed |
| To detect potential pathways and target genes in infantile Pompe patients using computational analysis. | Bioimpacts | 2022 | 35411297 | PubTator, text mining | PubMed |
| Hypothetical protein predicted to be tumor suppressor: a protein functional analysis. | Genomics Inform | 2022 | 35399005 | PubTator, text mining | PubMed |
| HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma. | Bioengineered | 2022 | 35389828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/papers?page=17